MEI PHARMA INC (MEIP) Stock Analyst Ratings
NASDAQ:MEIP - Nasdaq - US55279B3015 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 46% to MEIP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.12. This target is 126.25% above the current price.
MEIP was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about MEIP.
In the previous month the buy percentage consensus was at a similar level.
MEIP was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-07-23 | Laidlaw & Co. | Downgrade | Buy -> Hold |
| 2024-04-12 | Stifel | Maintains | Hold -> Hold |
| 2024-02-14 | Stifel | Maintains | Hold -> Hold |
| 2023-09-27 | Stifel | Maintains | Hold -> Hold |
| 2023-05-23 | Brookline Capital | Maintains | Buy -> Buy |
| 2023-05-12 | Stifel | Maintains | Hold -> Hold |
| 2023-02-13 | HC Wainwright & Co. | Maintains | Buy |
| 2023-02-08 | Jefferies | Downgrade | Hold -> Underperform |
| 2022-12-06 | BTIG | Downgrade | Buy -> Neutral |
| 2022-12-06 | Truist Securities | Downgrade | Buy -> Hold |
| 2022-02-03 | Jefferies | Initiate | Buy |